Cencora

Cencora in Fortune Rankings

Cencora, formerly AmerisourceBergen, is a global pharmaceutical-solutions company that sources, distributes, and supports prescription drugs, specialty medicines, over-the-counter products, medical supplies, and related services. Its U.S. Healthcare Solutions segment serves health systems, hospitals, physician practices, pharmacies, and other care sites through pharmaceutical distribution, specialty distribution, supply-chain, and pharmacy solutions. Cencora also provides biopharma and life-sciences services—including clinical-trial logistics, market access, regulatory support, commercialization, and patient-support services—and operates in more than 50 countries.

Updated:7/28/26
Country/Territory:U.S.
Headquarters:Conshohocken, Pa.
Industry:Wholesalers: Health Care
CEO:Robert P. Mauch
Website:https://www.cencora.com

Ticker:COR
Company type:Public
Revenues ($M):$321,333
Profits ($M):$1,554
Market value ($M):$59,561
Number of employees:49,000

Figures are for fiscal year ended Sept. 30, 2025. Market value as of July 13, 2026.

Sector:Stores and Distributors
Industry:Wholesalers: Health Care
Industry Rank:3
Previous Industry Rank:3
Overall Score:5.5

Due to weak distribution of responses, only the aggregate industry score and rank are published.

$ Millions% change
Revenues ($M):$321,332.89.3%
Profits ($M):$1,554.23%
Assets ($M):$76,590.1-
Total Stockholder Equity ($M):$1,508-

Profit as % of Revenues:0.5%
Profits as % of Assets:2%
Profits as % of Stockholder Equity:103.1%

Earnings Per Share ($):8.00
EPS % Change (from prior fiscal year):5.7%
EPS % Change (5 year annual rate):-
EPS % Change (10 year annual rate):-

Total Return to Investors (last year):51.5%
Total Return to Investors (5 year, annualized):29.6%
Total Return to Investors (10 year, annualized):14.2%

Cencora stock chart

Cencora in Fortune Rankings

View the Full List